The aim of this study was to investigate whether Gs-Rbl relieves the CoCl 2 -induced apoptosis of hypoxic neonatal rat cardiomyocytes and in which the role of glucose transporter-4 (GLUT-4). Methods: 10, 50, 100, 200, 400, and 500 µmol/L), adenine 9-β-D-arabinofuranoside (ara A, 500 µmol/L; AMPK inhibitor) and wortmannin (0.5 µmol/L; PI3K inhibitor) only in combination with 200 µmol/L Gs-Rbl were administered in hypoxic cardiomyocytes, which were induced by 500 µmol/L CoCl 2 for 12 h. Then, the apoptotic rate (AR), 2-
Introduction
Myocardial ischemia plunges heart muscle into an energy-deficient state, which does not satisfy the energy requirement of cardiomyocytes. Ischemia and hypoxia, if not corrected, can lead to cardiomyocyte "hibernation," apoptosis and even necrosis. Hibernating myocardium, an adaptive response to ischemia and/or metabolic imbalance [1] [2] [3] [4] [5] [6] , may result in characteristic ultrastructural changes in cardiomyocytes, such as myolysis and subsequent glycogen accumulation in the myolytic areas [3] [4] [5] [6] . Although it is reversible, cardiomyocyte "hibernation" and apoptosis will damage heart function to an extreme extent. Therefore, a method for improving cardiomyocytes' anti-hypoxic response has become an important area of cardiovascular research. In cardiomyocytes, glucose is the major metabolic substrate during ischemia and hypoxia. Its facilitative uptake is dependent on the activity of glucose transporters (GLUT) on the cell surface, in particular, glucose transporter-4 (GLUT-4) [7, 8] . The increase in glucose uptake is mainly dependent on GLUT-4 translocation via AMP-activated protein kinase (AMPK) [9] [10] [11] , phosphatidylinositol-3 kinase (PI3K) [12, 13] , etc. The increased glucose uptake provides a substrate for glycolysis and then partly compensates for the energy deficit.
Ginsenoside Rbl (Gs-Rbl), which is the main ginseno-side that is extracted from ginseng (the root of Panax ginseng C. A. Meyer, family Araliaceae) as a traditional medicine in Asian countries, contains an aglycone with a dammarane skeleton and has been reported to show various biological activities resisting ischemic reperfusion injury in myocardial infarction [14] [15] [16] . However, few reports exist regarding whether Gs-Rbl can prevent the apoptosis and death of hypoxic cardiomyocytes. Thus, we explored whether and how Gs-Rbl relieves hypoxia-induced apoptosis of neonatal rat cardiomyocytes ex vivo (ie, what role glucose uptake, GLUT-4 translocation, etc, play in Gs-Rbl-based protection against hypoxia in the present study.
Materials and methods
This study was implemented in accordance with the institutional guidelines for animal care of China Medical University and approved by the local animal research committee.
Cardiomyocyte culture Ventricles from 1-to 3-dayold Wistar rats [SCXK(Liao) 2003-0009, supplied by the Laboratory Animal Center of China Medical University] were minced and sequentially digested with phosphatebuffered saline (PBS) containing 0.08% trypsin and 0.05% collagenase II (Gibco company) at 37 °C for 10 min under sterile conditions; the procedure was repeated two to three times after collection of the cell suspension. The cell suspension was centrifuged (100×g, 10 min), and then cells were suspended in Dulbecco's modified Eagle's medium (DMEM) (Gibco) supplemented with 10% fetal bovine serum (FBS) (Gibco) and 0.1 mmol/L bromodeoxyuridine (to prevent nonmyocardial cells from proliferating) and incubated in 100-mL culture dishes (37 °C, 5% CO 2 , 95% air; NuAire 8000 Autoflow CO 2 Incubator; Thermo Electron Corporation, Franklin, MA) for 90 min to remove fibroblasts. Cardiomyocytes were separated according to their different adherence times, as previously described. Unattached cells (mainly cardiomyocytes) were seeded on culture flasks at a density of 1.0×10 5 cells per mL and then were incubated for 3 days before being used for experiments. About 85%-95% of cells were identified as cardiomyocytes by immunocytochemical staining with monoclonal antisarcomeric actin clone AC40-CY3 (Sigma).
CoCl 2 -induced hypoxia and Gs-Rb1 intervention According to a previous study [17] and our preliminary experiments with CoCl 2 -induced hypoxia, 500 µmol/L CoCl 2 was prepared fresh in culture medium. After 500 µmol/L CoCl 2 intervention, cardiomyocytes were incubated in L-DMEM supplemented with 10% FBS and different concentrations of fresh Gs-Rb1 (0, 10, 50, 100, 200, 400, and 500 µmol/L) for 12 h. In addition, adenine 9-β-D-arabinofuranoside (ara A, 500 µmol/L; AMPK inhibitor) and wortmannin (0.5 µmol/L; PI3K inhibitor) were administered for 12 h in the presence of 200 µmol/L Gs-Rb1.
Flow cytometric analysis of cardiomyocyte apoptosis The above-described cells were adjusted to 1.0×10 6 3 H]-DG were counted, and then glucose uptake (pmol/mg protein per 10 min) was determined. Net specific uptake was calculated as the difference between the total and nonspecific values, which was determined in the presence of excess D-glucose (100 mmol/L).
Plasma membrane preparation for GLUT-4 translocation assay Cardiomyocytes were washed (as indicated above), centrifuged at 600×g for 5 min and then homogenized in buffer A with protease inhibitors (Cell Fractionation Kit; Biovision, Mountain View, CA) for 50 min. After centrifugation at 20 000×g for 15 min, the pellet was resuspended and centrifuged at 110 000×g for 60min on a linear sucrose gradient with a density ranging from 1.05 to 1.25 g/mL in order to isolate the plasma membrane (PM), which are assayed for GLUT-4 protein. All centrifugations were carried out at 4 °C.
Immunocytochemistry The coverslips were removed from culture dishes and washed three times with PBS for 5 min per rinse; the coverslips were then fixed in PBS (pH 7.2) with 4% paraformaldehyde (PFA) for 20 min at 4 o C and washed twice with PBS for 15 min per rinse. According to the instructions for the GLUT-4 (Sigma) and Akt (Sigma) kits, primary antibodies against GLUT-4(1:200) and Akt (1:200) were incubated overnight at room temperature (with PBS as a negative control), and secondary antibodies (goat anti-rabbit lgG) conjugated to either HRP or Cy3 (Invitrogen) were employed, respectively. The cells were photographed. Buff-colored or red fluorescent grains on the cell membrane and/or in the cytoplasm suggested that the cells were positive; otherwise, we assumed that the cells were negative.
Western blotting The cardiomyocytes (1.0×10 7 ) used for Western blotting were immediately frozen in liquid nitrogen and stored at -80 °C until use. Total protein was extracted with ice-cold lysis buffer and centrifugation (4 o C, 12 000×g, 10 min). The protein (20 μL per sample) was subjected to 12% sodium dodecyl sulfate-polyacrylamide gel electrophoresis and transferred onto polyvinylidene difluoride membranes. The membranes were blotted with primary rabbit anti-rat antibodies to GLUT-4 (1:1000), phospho-AMPKα (Thr172, p-AMPKα), AMPKα, Akt (1:1000) and β-actin (1:1000). After incubation overnight at 4 °C, blots were rinsed in TTBS for 30 min and incubated in HRP-conjugated secondary antibody (goat anti-rabbit IgG, 1:2000); bands were visualized using chemiluminescence (Pierce, Rockford, IL). All of the above primary antibodies were purchased from Santa Cruz Biotechnology. Relevant band intensities were quantified after normalization to the amount of β-actin protein.
AMPK activity assay AMPK activity was measured as previously described. Briefly, both phospho-AMPKα (Thr172) and AMPKα were acquired by Western blot. AMPK activity was expressed as the ratio of p-AMPK relative to the total amount of AMPK (ie, defined as the optimal ratio of p-AMPKα to AMPKα).
Data analysis All the experiments were repeated three times. All data in this study are presented as means±SD. Statistical analysis was performed using one-way analysis of variance (ANOVA). P values <0.05 were considered significant. increases were observed from 50−400 µmol/L; no significant difference was observed between 400 and 500 µmol/L (P=0.315). In order to identify the correlation between glucose uptake and cell apoptosis, we found a strong negative correlation (r=-0.57, P=0.002), which suggested that Gs-Rb1 might prevent hypoxic cardiomyocytes from undergoing apoptosis by improving glucose uptake.
Effect of stimulants on GLUT-4 protein levels Despite hypoxia or Gs-Rb1 intervention, the GLUT-4 protein was expressed on the cell membranes and/or the cytoplasm of cardiomyocytes (Figure 3 ). To address GLUT-4 expression patterns in cells and PM, we evaluated it in treated cardiomyocytes. As shown in Figure 4 , GLUT-4 protein content in cells was significantly up-regulated up to 1.54±0.11-fold at 50 µmol/L, 2.29±0.20-fold at 100 µmol/L, 2.49±0.19-fold at 200 µmol/L, 2.50±0.14-fold at 400 µmol/L and 2.49±0.23-fold at 500 µmol/L when Gs-Rb1 was applied (10 µmol/L had no effect, P=0.148) compared with hypoxia. There was a significant dose-dependent increase from 50 to 200 µmol/L Gs-Rb1. Similar to GLUT-4 protein content in cells, Gs-Rb1 induced the expression of GLUT-4 to 1.66±0.10-(50 µmol/L), 1.84±0.07-(100 µmol/L), 2.01±0.14- 5 and 6 ). In accordance with glucose uptake and GLUT-4 expression, there was a significant dose-dependent increase in AMPK activity between 50 and 200 µmol/L (P<0.01) and no significant difference between 400 and 500 µmol/L Gs-Rb1 (P=0.573). To further determine whether AMPK activity mediated the above-mentioned role of Gs-Rb1 on CoCl 2 -induced hypoxia, ara-A, a competitive inhibitor of AMPK, was administered. Cardiomyocytes were randomized to either the ara-A group (incubated simultaneously Figure 4B ) and glucose uptake ( Figure 2) were significantly down-regulated, and the apoptosis ratio (Figure 1 ) was up-regulated when the ara-A group was compared with the non-ara-A group. 
Effect of stimulants on Akt protein levels

Discussion
Because hypoxia, a pathological state, may induce cardiomyocyte apoptosis, which is an important mode of cell death in various heart diseases, many scholars in the cardiovascular field have dedicated themselves to improve the anti-hypoxic capability of cardiomyocytes. Although ginseng is frequently used as a crude substance taken orally in many countries, its major component, Gs-Rb1, plays a role in improving ischemic reperfusion injury [14] [15] [16] ; however, the anti-hypoxic effect of Gs-Rb1 has rarely been analyzed. Because an effective dose of Gs-Rb1 has not been reported, we tested different Gs-Rb1 concentrations (0, 10, 50, 100, 200, 400, and 500 µmol/L), and we found that Gs-Rb1 could significantly decrease the apoptotic ratio of hypoxic cardiomyocytes induced by CoCl 2 . Of the doses tested, 200 µmol/L of Gs-Rb1 may be the optimal anti-hypoxic concentration. Our data suggested that Gs-Rb1 may effectively protect hypoxic cardiomyocytes from apoptosis in vitro. For a better understanding of how Gs-Rb1 exerts its anti-apoptotic effect, we investigated glucose uptake and GLUT-4, among other potential mechanisms.
The predominant substrate for cardiac energy metabolism during ischemia/hypoxia is glucose; therefore, increasing glucose uptake may prevent cardiomyocytes from undergoing apoptosis once they are hypoxic. Treatment of cells with 500 µmol/L CoCl 2 significantly increases the apoptotic ratio and inhibits glucose uptake; thus, Gs-Rb1 was administered to hypoxic cardiomyocytes (induced with 500 µmol/L CoCl 2 ) ex vivo in order to determine both the efficacy and the mechanism of Gs-Rb1. Our results, in which Gs-Rb1 significantly increased glucose uptake in a dose-dependent manner compared with hypoxic cells and a strong negative correlation existed between glucose uptake and apoptosis, suggested that Gs-Rb1 may prevent the apoptosis of hypoxic cardiomyocytes as a result of improved glucose uptake.
Glucose enters cardiomyocytes by facilitative transport, a process that is mainly mediated by GLUT-4 proteins [7, 8] . The sustained increase in glucose uptake in cardiomyocytes mainly depended on both translocation and expression of GLUT-4, and translocation (ie, constitutively residing at the cell surface to optimize cell exposure to extracellular glucose) is particularly important [18] . In the physiological state of the cells, GLUT-4 is found on cell membranes and in the intracellular compartment; once the cell encounters stress, such as hypoxia [19] , ischemia [20] , etc. [21] [22] [23] , GLUT-4 can be rapidly translocated to the cell surface, allowing the cell to transiently increase its access to extracellular glucose [24] [25] . Cardiac glucose uptake and glycolysis are protective in the ischemic heart [26] , and glucose transporter deficiency decreases ischemic tolerance [27] . In the present study, we have shown that GLUT-4 was expressed at higher levels and readily exchanged with the cell surface and presumably endosomes in hypoxic cardiomyocytes after exposure to Gs-Rb1. Thus, it is likely that both GLUT-4 translocation and expression play key roles in Gs-Rb1-induced, persistent, increased glucose uptake in hypoxic cardiomyocytes.
A growing number of in-vivo [28] [29] [30] [31] and in-vitro [32] studies have indicated that AMPK activation may directly regulate GLUT-4 expression [11, [28] [29] [30] [31] [32] [33] and induce a significant increase in glucose uptake [9] [10] [11] [28] [29] [30] [31] [32] [33] [34] in cultured skeletal muscle cells. In cardiomyocytes, hypoxia may increase AMPK-mediated glucose uptake and GLUT-4 translocation [35] , which is not sufficient to increase glucose uptake [36] . In the present study, Gs-Rb1 significantly increased AMPK activity in a dose-dependent manner up to a threshold concentration. AMPK phosphorylation can be regulated by its physiological regulators, including upstream kinases (Ca 2+ /calmodulindependent protein kinase kinases) and LKB1 and the cellular AMP/ATP ratio. Whether the efficacy of Gs-Rb1 on AMPK activity was also mediated by these regulators requires further investigation. To further determine the role of AMPK in Gs-Rb1 anti-hypoxia, ara-A (a competitive inhibitor of AMPK) was also employed in our present study. The results showed that AMPK activity was wholly inhibited, both glucose uptake and GLUT-4 translocation (including expression) were partly inhibited, and the apoptotic ratio was up-regulated by ara-A. These findings suggested that Gs-Rb1 may protect cardiomyocytes from apoptosis by other mechanisms beside AMPK. To summarize, AMPK activity was an important regulator of Gs-Rb1's anti-hypoxic effect on cardiomyocytes, which may be part of a signaling cascade, such as, both myocardial glucose uptake and glycolysis are activated, followed by an increase in fatty acid oxidation.
In this study of how Gs-Rb1 protects cardiomyocytes from apoptosis, we found that Gs-Rb1 could also significantly up-regulate Akt expression and that this expression was entirely abrogated by preincubation with wortmannin, a competitive inhibitor of phosphatidylinositol 3-kinase (PI3K) activity. Thus, it appeared that PI3K activity was necessary for the Akt-mediated effects of Gs-Rb1. Akt, a serine/threonine kinase that acts downstream of PI3K, is activated by a dual mechanism involving the binding of phosphatidylinositol 3,4,5-trisphosphate (PIP 3 ) [37] to the Akt PH domain [38] , as well as phosphorylation of either phosphatidylinositol 3,4-bisphosphate (PIP 2 ) or serine/threonine by one or more Akt kinases. It was possible that PI3K pathway is the main downstream pathway of Gs-Rb1. Many studies have demonstrated that PI3K/Akt may be necessary for GLUT-4 translocation [12, 13, 39, 40] and glucose uptake. Consistent with these findings, the present results -in which the effects of Gs-Rb1, were partly inhibited by wortmannin without Akt activation -indicated that PI3K was partly responsible for the efficacy of Gs-Rb1. In addition, PI3K also phosphorylates the insulin receptor substrate-1 (IRS-1), an in vitro substrate for this activity [41, 42] , and exhibits both lipid and protein kinase activities, all of which may play an important role in the effects of Gs-Rb1. In the mechanism through which Gs-Rb1 protects cardiomyocytes from apoptosis, it is important to determine whether PI3K can affect Gs-Rb1 via pathways beside Akt. Briefly, Gs-Rb1 may allow cardiomyocytes to survive under hypoxic conditions through the activation of Akt as a PI3K-dependent upstream activator of GLUT-4 translocation.
The balance between anti-apoptotic and pro-apoptotic proteins [43, 44] , the release of cytochrome c from mitochondria, caspase activation, and the activation of protein kinase C isozymes may reduce myocardial apoptosis. Whether Gs-Rb1 decreases pro-apoptotic Bax, increases the antiapoptotic Bcl-2 proteins, resulting in an altered Bcl-2/Bax ratio, attenuates cytochrome c release from mitochondria or inhibits caspase activity must still be demonstrated.
In conclusion, our findings present direct evidence supporting the role of Gs-Rb1 in protecting hypoxic cardiomyocytes from apoptosis. In addition, the stimulation of GLUT-4 translocation and glucose transport activity and the lack of hypoxia-induced apoptosis inhibition by either ara-A or wortmannin suggested that the effect of Gs-Rb1 may be the result of several pathways in addition to AMPK and PI3K. Nevertheless, these results suggested that both AMPK and PI3K played an important role in the determination of overall glucose utilization. However, future experiments will be necessary to determine the precise mechanism of Gs-Rb1 in mediating this efficacy.
